It is very uncertain whether COMPARISON 1. ARIPIPRAZOLE changes leaving the study early ‐ Any reason compared with CLOZAPINE (very low certainty).
It is very uncertain whether humour‐based interventions changes leaving the study early for any reason compared with standard care (very low certainty).
Mirtazapine adjunct showed no clear difference in leaving the study early for any reason compared with placebo adjunct (moderate certainty).
Music therapy showed no clear difference in leaving the study early Up to 3 months compared with psychological treatment (moderate certainty).
It is very uncertain whether active music therapy changes leaving the study early Up to 3 months compared with receptive music therapy (very low certainty).
Music therapy plus treatment as usual (TAU) showed no clear difference in leaving the study early Up to 3 months compared with TAU (moderate certainty).
Adjunct cognitive behavioural therapy showed no clear difference in adverse event: Leaving the study early compared with adjunct supportive psychotherapy (moderate certainty).
It is very uncertain whether EMDR changes leaving the study early for any reason compared with non‐TFCBT (very low certainty).
It is very uncertain whether group TFCBT changes leaving the study early for any reason compared with waitlist/Usual Care (very low certainty).
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with waitlist/Usual Care (very low certainty).
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with non‐TFCBT (very low certainty).
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with other therapies (very low certainty).
H2 antagonists showed no clear difference in leaving the study early: for any reason compared with placebo (low certainty).
Monoamine modulators showed no clear difference in leaving the study early: for any reason compared with placebo (low certainty).
Topiramate showed no clear difference in leaving the study early: for any reason compared with placebo or no treatment (low certainty).